Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
After a decade testing PCs, routers, and networks, I know what really slows things down - and how to optimize your connection.
Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback